Johnson & Johnson Market Cap

Johnson & Johnson has a market cap or net worth of $547.51 billion as of January 30, 2026. Its market cap has increased by 56.87% in one year.

Market Cap

547.51B

Enterprise Value

574.75B

1-Year Change

56.87%

Ranking

#19

Market Cap Chart

Since December 1, 1998, Johnson & Johnson's market cap has increased from $108.92B to $547.51B, an increase of 402.68%. That is a compound annual growth rate of 6.12%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	547.51B	9.81%
Dec 31, 2025	498.60B	43.20%
Dec 31, 2024	348.19B	-7.72%
Dec 29, 2023	377.32B	-18.30%
Dec 30, 2022	461.85B	2.55%
Dec 31, 2021	450.36B	8.70%
Dec 31, 2020	414.31B	7.92%
Dec 31, 2019	383.91B	10.92%
Dec 31, 2018	346.11B	-7.79%
Dec 29, 2017	375.36B	19.76%
Dec 30, 2016	313.43B	10.28%
Dec 31, 2015	284.22B	-2.90%
Dec 31, 2014	292.70B	13.27%
Dec 31, 2013	258.42B	33.02%
Dec 31, 2012	194.27B	8.47%
Dec 30, 2011	179.09B	5.44%
Dec 31, 2010	169.86B	-4.42%
Dec 31, 2009	177.71B	7.05%
Dec 31, 2008	166.00B	-13.03%
Dec 31, 2007	190.88B	-0.28%
Dec 29, 2006	191.42B	7.06%
Dec 30, 2005	178.79B	-5.00%
Dec 31, 2004	188.21B	22.75%
Dec 31, 2003	153.33B	-3.90%
Dec 31, 2002	159.55B	-11.43%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	928.64B
AbbVie	394.14B
AstraZeneca	289.37B
Novartis AG	285.27B
Merck & Co.	273.69B
Novo Nordisk	261.22B
Amgen	184.10B
Gilead Sciences	176.11B

Market Cap Rankings